Standard Biotools (LAB) Change in Cash (2010 - 2026)

Standard Biotools (LAB) has 17 years of Change in Cash data on file, last reported at $144.6 million in Q1 2026.

• Change in Cash for Q1 2026 came in at $144.6 million, up 1042.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $114.4 million (up 184.82% YoY), and the FY2025 annual result was -$45.5 million, down 139.14% from the prior year.
• Change in Cash advanced to $144.6 million in Q1 2026 per LAB's latest filing, from -$8.7 million in the prior quarter.
• Over five years, Change in Cash peaked at $235.8 million in Q1 2024 and troughed at -$62.6 million in Q3 2023.
• A 5-year average of $14.0 million and a median of -$8.7 million in 2025 frame the typical range for Change in Cash.
• On a YoY basis, Change in Cash climbed as much as 1997.52% in 2023 and fell as far as 342.37% in 2023.
• A 5-year view of Change in Cash shows it stood at $21.1 million in 2022, then slumped by 232.41% to -$28.0 million in 2023, then tumbled by 54.27% to -$43.1 million in 2024, then soared by 79.8% to -$8.7 million in 2025, then surged by 1759.79% to $144.6 million in 2026.
• Business Quant data shows LAB's Change in Cash at $144.6 million in Q1 2026, -$8.7 million in Q4 2025, and -$29.2 million in Q3 2025.